{
    "pmcid": "9896449",
    "qa_pairs": {
        "What immunization strategy was used to elicit a diverse set of VNARs in nurse sharks?": [
            "Nurse sharks were immunized with SARS-CoV-2 spike receptor binding domain (RBD), RBD-ferritin (RFN), and spike-ferritin nanoparticles (SpFN).",
            "Nurse sharks were immunized with SARS-CoV-2 nucleocapsid protein and membrane protein.",
            "Nurse sharks were immunized with SARS-CoV-2 envelope protein and non-structural proteins.",
            "Nurse sharks were immunized with SARS-CoV-2 spike protein alone without any modifications."
        ],
        "What structural feature of shark-derived nanobodies allows them to access less accessible epitopes compared to conventional antibodies?": [
            "Their small size and robust stability",
            "Their large size and complex structure",
            "Their high molecular weight and rigid conformation",
            "Their low variability and limited flexibility"
        ],
        "What was the outcome of testing ShAb01 and ShAb02 in a K18-hACE2 transgenic mouse model?": [
            "ShAb01 and ShAb02 provided significant protection against SARS-CoV-2 challenge, with ShAb01 showing greater protection.",
            "ShAb01 and ShAb02 failed to provide any protection against SARS-CoV-2 challenge.",
            "ShAb01 provided protection, but ShAb02 showed no effect against SARS-CoV-2 challenge.",
            "Neither ShAb01 nor ShAb02 showed any significant protection in the mouse model."
        ],
        "What was the result of engineering multi-specific nanobodies combining the specificities of ShAb01 and ShAb02?": [
            "Improved neutralization potency and breadth against SARS-CoV-2 variants",
            "Decreased neutralization potency and specificity against SARS-CoV-2 variants",
            "No change in neutralization potency or breadth against SARS-CoV-2 variants",
            "Reduced binding affinity and loss of ACE2 blocking activity"
        ],
        "Which two representative shark antibody variable NAR-Fc chimeras were identified in the study?": [
            "ShAb01 and ShAb02",
            "ShAb03 and ShAb04",
            "ShAb05 and ShAb06",
            "ShAb07 and ShAb08"
        ]
    }
}